PATENT CLAIM ANALYSIS

Application Number: 15866669
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["540", "465000"]

Abstract:
The present invention relates to a theranostic system comprising a beacon and a compound selected from the group consisting of a quinazoline-based tyrosine kinase inhibitor and a natural product. The theranostic systems have use in the therapy and diagnosis of tyrosine kinase related malignancies.

Claim (Index 14):
A theranostic system according to any one of  claims 1  to  11 , wherein the system comprises a complex of the natural product and the beacon represented by Formula H or a complex selected from the group consisting of

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.39394
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14751795', '10704120', '12209738', '11852604', '11807201']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.692903690629026
- 35 USC 102 Novelty (BERT): 0.5958854245813445
- Combined Prediction Score: 0.683201864024258
- Mean Citation Score: 314.902338
- Max Citation Score: 570.9696
- Similarity Product: 394.9841422645569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test